Skip to main navigation Skip to search Skip to main content

Response to: Correspondence on "g-CSF as a suitable alternative to GM-CSF to boost dinutuximab-mediated neutrophil cytotoxicity in neuroblastoma treatment" by Mora et al

Research output: Contribution to journalLetterpeer-review

1 Citation (Scopus)
Original languageEnglish
Article numbere003983
JournalJournal for ImmunoTherapy of Cancer
Volume9
Issue number12
DOIs
Publication statusPublished - 1 Dec 2021

Keywords

  • cytokines
  • immunotherapy
  • neuroblastoma

Cite this